Patient parameters and response after administration of rituximab in pediatric mature B‐cell non‐Hodgkin lymphoma-Reference-Cited by-同舟云学术

Patient parameters and response after administration of rituximab in pediatric mature B‐cell non‐Hodgkin lymphoma

Published:2021-12-22 Issue: Volume: Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Bethke Maria¹,Varga Georg²,Weinhage Toni²,Sabharwal Harshana¹,Mellgren Karin³,Randau Gerrit¹,Rolfing Meike¹,Wittkowski Helmut²,Foell Dirk²,Michgehl Ulf¹^ORCID,Burkhardt Birgit¹

Affiliation:

1. Pediatric Hematology and Oncology University Children's Hospital Muenster Münster Germany

2. Department of Pediatric Rheumatology and Immunology University Hospital Muenster Münster Germany

3. Department of Pediatric Oncology and Hematology Sahlgrenska University Hospital, The Queen Silvia Children's Hospital Gothenburg Sweden

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29514

Reference44 articles.

1. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence

2. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

3. Burkitt's lymphoma

4. Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM‐type first‐line therapy;Woessmann W;Blood,2020

5. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion, and contributes to rituximab resistance in diffuse large B-cell lymphoma;Journal of Biological Chemistry;2024-03

2. B cell subsets reconstitution and immunoglobulin levels in children and adolescents with B non-Hodgkin lymphoma after treatment with single anti CD20 agent dose included in chemotherapeutic protocols: single center experience and review of the literature;Biomedical Papers;2023-05-23

3. S100A8 and S100A9 in Cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-05

4. CORRELATION BETWEEN THE EXPRESSION OF S100A12 IN THE BLOOD AND SYNOVIUM AND THE SEVERITY OF HIP OSTEOARTHRITIS;ACTA MEDICA MEDITERR;2022